| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
C-type lectin domain containing 16A | 0.612 | 0.654 | 0.28 |
|
disease | 0.500 | None | 1.000 | 6 | 15 | 2007 | 2020 | ||||||||
|
protein tyrosine phosphatase non-receptor type 22 | 0.438 | 0.846 | 3.5E-21 |
|
disease | 0.900 | None | 0.945 | 4 | 1 | 2004 | 2020 | ||||||||
|
BTB domain and CNC homolog 2 | 0.539 | 0.731 | 1.00 |
|
disease | 0.430 | None | 1.000 | 4 | 3 | 2008 | 2016 | ||||||||
|
erb-b2 receptor tyrosine kinase 3 | 0.448 | 0.808 | 1.7E-15 |
|
disease | 0.200 | None | 1.000 | 4 | 2 | 2007 | 2019 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 1 | 0.416 | 0.846 | 2.4E-02 |
|
disease | 0.500 | None | 0.948 | 3 | 3 | 1988 | 2019 | ||||||||
|
C1q and TNF related 6 | 0.682 | 0.577 | 9.0E-06 |
|
disease | 0.410 | None | 1.000 | 3 | 2 | 2008 | 2015 | ||||||||
|
interferon induced with helicase C domain 1 | 0.471 | 0.808 | 7.0E-44 |
|
disease | 0.200 | None | 0.927 | 3 | 1 | 2006 | 2018 | ||||||||
|
ubiquitin associated and SH3 domain containing A | 0.638 | 0.538 | 1.0E-10 |
|
disease | 0.160 | None | 1.000 | 3 | 2 | 2009 | 2019 | ||||||||
|
N-alpha-acetyltransferase 25, NatB auxiliary subunit | 0.603 | 0.692 | 1.00 |
|
disease | 0.120 | None | 1.000 | 3 | 1 | 2007 | 2010 | ||||||||
|
SH2B adaptor protein 3 | 0.527 | 0.692 | 1.0E-04 |
|
disease | 0.460 | None | 1.000 | 2 | 1 | 2008 | 2018 | ||||||||
|
GLIS family zinc finger 3 | 0.590 | 0.654 | 5.6E-08 |
|
disease | 0.440 | None | 1.000 | 2 | 2 | 2009 | 2017 | ||||||||
|
cathepsin H | 0.626 | 0.654 | 1.3E-08 |
|
disease | 0.430 | None | 1.000 | 2 | 1 | 2008 | 2015 | ||||||||
|
protein tyrosine phosphatase non-receptor type 2 | 0.538 | 0.692 | 1.00 |
|
disease | 0.200 | None | 0.950 | 2 | 1 | 2008 | 2019 | ||||||||
|
INS-IGF2 readthrough | 0.633 | 0.500 | 5.6E-02 |
|
disease | 0.170 | None | 0.923 | 2 | 2 | 1991 | 2019 | ||||||||
|
major histocompatibility complex, class II, DR alpha | 0.581 | 0.769 | 0.52 |
|
disease | 0.140 | None | 1.000 | 2 | 4 | 2007 | 2019 | ||||||||
|
ataxin 2 | 0.482 | 0.808 | 0.85 |
|
disease | 0.100 | None | 1.000 | 2 | 1 | 2009 | 2018 | ||||||||
|
interleukin 2 receptor subunit alpha | 0.389 | 0.885 | 5.5E-02 |
|
disease | 0.500 | None | 0.959 | 1 | 1 | 1984 | 2019 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
disease | 0.500 | None | 0.927 | 1 | 1 | 1998 | 2020 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.500 | None | 0.946 | 1 | 5 | 1988 | 2020 | ||||||||
|
tyrosine kinase 2 | 0.505 | 0.769 | 4.5E-08 |
|
disease | 0.430 | None | 1.000 | 1 | 1 | 2010 | 2018 | ||||||||
|
CD69 molecule | 0.488 | 0.923 | 3.0E-02 |
|
disease | 0.410 | None | 1.000 | 1 | 1 | 2009 | 2019 | ||||||||
|
protein kinase C theta | 0.636 | 0.654 | 0.30 |
|
disease | 0.400 | None | 1.000 | 1 | 1 | 2008 | 2009 | ||||||||
|
major histocompatibility complex, class II, DP beta 1 | 0.453 | 0.923 | 5.3E-10 |
|
disease | 0.200 | None | 0.882 | 1 | 1 | 1990 | 2017 | ||||||||
|
major histocompatibility complex, class II, DQ beta 2 | 0.573 | 0.731 | 4.3E-02 |
|
disease | 0.200 | None | 1.000 | 1 | 7 | 1990 | 2018 | ||||||||
|
lymphotoxin alpha | 0.434 | 0.885 | 0.20 |
|
disease | 0.200 | None | 0.929 | 1 | 4 | 1991 | 2014 |